Revenue
$29.7B
Gross Margin
+79.4%
Operating Margin
+38.3%
Net Margin
+31.0%
Income statement waterfall for Gilead Sciences (GILD) — TTM through Q1 2026
Net income: $9.22B
Margin breakdown for Gilead Sciences (GILD) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $29.7B | $29.7B |
| Cost of Revenue | -$6.14B | $23.6B |
| Gross Profit | $23.6B | $23.6B |
| Operating Expenses | -$12.2B | $11.4B |
| Operating Income | $11.4B | $11.4B |
| Other Income / Expense | -$647M | $10.7B |
| Pre-tax Income | $10.7B | $10.7B |
| Income Tax | -$1.51B | $9.22B |
| Net Income | $9.22B | $9.22B |
- Revenue$29.7B
- Cost of Revenue-$6.14B
- Gross Profit$23.6B
- Operating Expenses-$12.2B
- Operating Income$11.4B
- Other Income / Expense-$647M
- Pre-tax Income$10.7B
- Income Tax-$1.51B
- Net Income$9.22B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks0.93% TTM
- Dividend Profile2.47% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.